Front & Back Matter.
- Published in:
- Neuroimmunomodulation, 2019, v. 25, n. 4, p. N.PAG, doi. 10.1159/000497000
- Publication type:
- Article
Works matching IS 1021-7401 AND VI 25 AND IP 4 AND DT 2019
Results: 8
1
2
Erratum.
- Published in:
- 2019
- Publication type:
- Correction Notice
3
A Promising New Approach for the Treatment of Inflammatory Pain: Transfer of Stem Cell-Derived Tyrosine Hydroxylase-Positive Cells.
- Published in:
- Neuroimmunomodulation, 2019, v. 25, n. 4, p. 225, doi. 10.1159/000495349
- By:
- Publication type:
- Article
4
Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
- Published in:
- Neuroimmunomodulation, 2019, v. 25, n. 4, p. 215, doi. 10.1159/000494976
- By:
- Publication type:
- Article
5
Serum Bilirubin and Albumin in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
- Published in:
- Neuroimmunomodulation, 2019, v. 25, n. 4, p. 206, doi. 10.1159/000494801
- By:
- Publication type:
- Article
6
CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson's Disease.
- Published in:
- Neuroimmunomodulation, 2019, v. 25, n. 4, p. 201, doi. 10.1159/000494435
- By:
- Publication type:
- Article
7
Crosstalk between Estrogen Withdrawal and NFκB Signaling following Penetrating Brain Injury.
- Published in:
- Neuroimmunomodulation, 2019, v. 25, n. 4, p. 193, doi. 10.1159/000493506
- By:
- Publication type:
- Article
8
Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder.
- Published in:
- Neuroimmunomodulation, 2019, v. 25, n. 4, p. 185, doi. 10.1159/000489561
- By:
- Publication type:
- Article